HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suzuki, S. Articles by Giovannucci, E. Search for Related Content PubMed PubMed Citation Articles by Suzuki, S. Articles by Giovannucci, E. Agricola Articles by Suzuki, S. Articles by Giovannucci, E.

Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia^1,2,3

¹ From the Departments of Nutrition (SS), of Health and Social Behavior (IK), and of Nutrition and Epidemiology (WCW and EG), Harvard School of Public Health, Boston; the Channing Laboratory, Department of Medicine, Brigham & Women's Hospital, Boston (WCW and EG); Harvard Medical School, Boston (WCW and EG); and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore (EAP).

See corresponding editorial on page 605.

² Supported by Public Health Service grants DK45779 and CA55075 from the Department of Health and Human Service, the National Institutes of Health.

³ Address reprint requests to E Giovannucci, Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115. E-mail: hpelg{at}channing.harvard.edu.

	ABSTRACT

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFEsRENCES

 
Background: Benign prostatic hyperplasia (BPH) is a common disease of older men. Although the etiology remains unclear, nutritional factors may have an effect on the disease.

Objective: Because the literature on the relations between macronutrient intakes and BPH risk is limited, we examined these relations among men in the Health Professionals Follow-up Study.

Design: We followed men aged 40–75 y from baseline in 1986 to 1994. Total BPH cases (n = 3523) comprised men who reported BPH surgery (n = 1589) or who did not undergo surgery but scored 15–35 points on the lower urinary tract symptom questionnaire of the American Urological Association (n = 1934); noncases were men who scored 7 points (n = 24388). Odds ratios (ORs) and 95% CIs were calculated by using multivariate logistic regression.

Results: The ORs rose with increasing total energy intake in a comparison of the highest and lowest quintiles for total BPH (OR: 1.29; 95% CI: 1.14, 1.45) and symptoms of BPH (1.43; 1.23, 1.66). Energy-adjusted total protein intake was positively associated with total BPH (1.18; 1.05, 1.33) and BPH surgery (1.26; 1.06, 1.49). Energy-adjusted total fat intake was not associated with risk of total BPH, but intakes of eicosapentaenoic, docosahexaenoic, and arachidonic acids were associated with a moderate increase in risk of total BPH.

Conclusions: We observed modest direct associations between BPH and intakes of total energy, protein, and specific long-chain polyunsaturated fatty acids. Because eicosapentaenoic, docosahexaenoic, and arachidonic acids are highly unsaturated fatty acids, our findings support a possible role of oxidative stress in the etiology of BPH.

Key Words: Benign prostatic hyperplasia • calories • energy • macronutrients • cohort study • protein • polyunsaturated fat • men • Health Professionals Follow-up Study

	INTRODUCTION

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFEsRENCES

 
Benign prostatic hyperplasia (BPH) is a common disease of older men, characterized by overgrowth of the prostatic epithelium and fibromuscular tissue of the transition zone and periurethral area and by obstructive and irritative lower urinary tract symptoms (1). Autopsy data indicate that anatomic or microscopic evidence of BPH is present in 40% and 90% of men aged 50–60 and 80–90 y, respectively (2). More than 200000 transurethral resections of the prostate for BPH are performed annually in the United States (3).

The etiology of BPH is unclear, but it appears to represent a multifactorial process involving both mechanical and dynamic components (4). Enlarged prostate, a mechanical or static component of BPH, is influenced mainly by androgens and can be pharmacologically treated with 5-reductase inhibitors to block intraprostatic conversion of testosterone to the more potent dihydrotestosterone (DHT) (5). Lower urinary tract symptoms due to a heightened tone of the prostatic smooth muscle, the dynamic component of BPH, are controlled by the sympathetic nervous system. ₁-Adrenergic receptor blockers, which are commonly used to alleviate these symptoms, act by relaxing prostatic smooth muscle (6).

Dietary and nutritional factors may have an effect on BPH etiology through a variety of mechanisms, but the literature on this topic is sparse (7–10). The absolute amount and composition of macronutrients may influence sympathetic nervous system activity and hormone concentrations. For example, a high total energy intake may elevate sympathetic nervous system activity and concentrations of testosterone (11). In addition, the macronutrient composition of the diet may be important. In particular, a high consumption of unsaturated fatty acids may contribute to lipid peroxidation of the cell membrane and of the components and fluidity of cell membranes, which may affect 5-reductase activity (12). One group noted age-related changes in the fatty acid composition of the prostate epithelium and stroma in men with BPH (13).

Because the literature on relations between macronutrient intakes and BPH risk is limited, we examined the relations between macronutrient intakes and total BPH, BPH surgery, lower urinary tract symptoms, and enlarged prostate among men in the Health Professionals Follow-up Study.

	SUBJECTS AND METHODS

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFEsRENCES

 
Study population
The Health Professionals Follow-up Study is an ongoing prospective cohort study of 51529 male dentists, veterinarians, pharmacists, optometrists, osteopathic physicians, and podiatrists. The participants, who were between 40 and 75 y of age at enrollment in 1986, completed a semiquantitative food-frequency questionnaire and provided information on age, race or ethnicity, weight, height, physical activity, cigarette smoking, alcohol consumption, and medical history (14). We collected updated information on exposure and disease biennially and on dietary intakes every 4 y via mailed follow-up questionnaires. The study was approved by the Human Research Committee at the Harvard School of Public Health.

On the 1988, 1990, 1992, and 1994 questionnaires, we asked participants whether they had undergone BPH surgery, usually a transurethral resection. In 1988 we mailed a confirmatory follow-up letter to a sample of respondents who reported such surgery. Of 99 randomly selected participants who confirmed having had a transurethral resection of the prostate, 77 granted us permission to review their medical records. We obtained medical records for 74 of these 77 participants, which confirmed the procedure. We subsequently considered the participant's self-report of BPH surgery as sufficient. Details of the cohort and follow-up techniques can be found elsewhere (15).

On the 1992 and 1994 questionnaires, we used a slightly modified version of the American Urological Association symptom index (16) to assess what percentage of the time (0%, 10%, 25%, 50%, 75%, or almost 100%) the participants experienced the following lower urinary tract symptoms during the past month: having a sensation of incomplete bladder emptying, having to urinate again after <2 h, stopping and starting several times during urination, difficulty postponing urination, having a weak urinary stream, and having to push or strain to begin urination. We also asked how many times per night the participant arose to urinate (0, 1, 2, 3, 4, 5, or 6). Each symptom was assigned a score of 0–5, corresponding to the percentage of the time that a symptom score was reported. We summed the points for each of the 6 lower urinary tract symptoms and the number of times per night the participant arose to urinate (we assigned a 5 for 5 times/night). The minimum possible score was 0 and the maximum was 35. On the 1992 questionnaire, we asked the men whether they had had an enlarged prostate detected by digital-rectal examination after 1986 and whether in the past 2 y they had had a digital-rectal examination.

At baseline we excluded men with an invalid dietary questionnaire (>70 blanks or an implausible energy intake) from 1986 (n = 1595), men who had a history of cancer (except for nonmelanoma skin cancer) or surgery for BPH before 1986 or prostate cancer during follow-up (n = 5237), and men who died (n = 442) before the 1988 questionnaire was mailed (the first opportunity to report BPH surgery). This left 44488 men in the baseline population. Of the men who had not had BPH surgery throughout the follow-up period, we excluded those who did not respond to the questions about lower urinary tract symptoms in 1992, which left 33344 men among whom to identify noncases and nonsurgery cases defined by symptoms.

Assessment of nutrients
The diet questionnaire used in the Health Professionals Follow-up Study was a 131-item validated semiquantitative food-frequency questionnaire aimed at accounting for >90% of the intake of major nutrients for the cohort (14,17). For each food, a commonly used unit or portion size was specified, and participants were asked how often on average during the past year they consumed that amount of each food. Each item had 9 possible responses, ranging from never to 6 times/d. We also asked about the usual brand of breakfast cereal consumed; the brand, dose, duration, and frequency of multivitamin and individual vitamin supplement used; and the types of fat commonly used for cooking and at the table. The questionnaire also contained an open-ended section about foods that were not specified. We computed nutrient intakes by multiplying the frequency of consumption of the given portion size of each food by the nutrient content in that food with the use of values from US Department of Agriculture sources (18) and other data. In the present study we examined intakes of total energy (excluding energy from alcohol), total fat, total protein, and total carbohydrate in relation to BPH risk. Protein was further analyzed separately by animal protein and vegetable protein. We considered separately animal and vegetable fats; saturated, monounsaturated, and polyunsaturated fats; and the individual fatty acids palmitic (16:0), stearic (18:0), oleic (18:1), linoleic (18:2n-6), -linolenic (18:3n-3), arachidonic (20:4n-6), eicosapentaenoic (EPA; 20:5n-3), and docosahexaenoic (DHA; 22:6n-3) acids. In all of the analyses, we used nutrients adjusted for energy with the use of the residuals method (11).

Classification of BPH cases and noncases
For the analyses we used 4 case definitions of BPH: 1) surgery for enlarged prostate between the date of return of the 1986 baseline questionnaire and 31 December 1993 (n = 1589); 2) high-moderate to severe lower urinary tract symptoms reported on the 1992 or 1994 questionnaire among those who did not undergo surgery for BPH (n = 1934); 3) total BPH, consisting of surgery-defined cases and symptom-defined cases (n = 3523); and 4) enlarged prostate detected by digital-rectal examination between 1986 and 1992 (n = 3180). The men were considered to have high-moderate to severe lower urinary tract symptoms if they scored 15–35 points on the American Urological Association symptoms index; men with a total symptom score of 8–14 points out of 35 (low-moderate symptoms; n = 5433) were not considered to be either cases or noncases.

Noncases were defined as men who had not had BPH surgery and whose total lower urinary tract symptom score in both 1992 and 1994 was between 0 and 7 points, or was between 0 and 7 points on the 1992 questionnaire if the 1994 symptom questions were not completed, irrespective of the result of the digital-rectal examination; 24388 men fit these criteria. In the analysis of enlarged prostate, noncases were men who reported having had normal results from a digital-rectal examination in the past 2 y, irrespective of symptom score (n = 15911).

Statistical analysis
We calculated odds ratios (ORs) and corresponding 95% CIs for each BPH definition and their associations with nutrient intakes from age- and energy-adjusted and multivariate logistic regression models. In the primary analyses, we considered the nutrients in quintiles. Because of the large number of cases, we also compared men in the top and bottom deciles of exposure to examine more extreme contrasts. Factors included in the multivariate logistic regression models were those for which distributions varied both by disease status and by nutrient intake or those that are risk factors for BPH in this population, ie, age (3-y categories), total energy (excluding that from alcohol), race or ethnicity (southern European, Scandinavian, other white, African American, Asian, and other) (19), physical activity in quintiles (20), cigarette smoking status [never, former, current (1–14, 15–34, and 35 cigarettes/d), and current unknown] (21), and alcohol consumption (5 categories) (21). In this cohort, central adiposity was positively associated with BPH (22). However, because waist circumference—from which central adiposity can be estimated, was available only for a subset of men, we used body mass index (BMI) instead. To determine whether the association between nutrient intake and BPH risk varied by level of obesity, we entered a series of indicator terms for cross-categories of BMI [tertiles of weight (in kg) divided by height squared (in m)] and nutrients (quintiles) in the multivariate logistic regression models. We evaluated interactions between BMI and nutrient intake by entering the cross-product of BMI and the nutrient along with the main-effect terms as continuous variables in the multivariate logistic regression models. Because total energy intake was entered in the model, the OR for each quintile of a specific nutrient can be interpreted as the OR when the amount of energy (compared with the median of the lowest quintile) from the nutrient is substituted for the same amount of energy from the other nutrients not included in the model. To evaluate trend, the midpoints of each category of intake of each nutrient were entered as a single continuous variable in the logistic regression models. All analyses were conducted with the use of SAS release 6.12 (SAS Institute, Cary, NC).

	RESULTS

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFEsRENCES

 
Of the 33344 men with complete data, 3523 men were considered to have BPH; 1589 men reported having had surgery for BPH between 1986 and 1994, and 1934 men reported lower urinary tract symptoms classified as high-moderate to severe in 1992 or 1994. In addition, 5433 men reported lower urinary tract symptoms that were classified as low-moderate; these men were not included in the analysis. The 24388 remaining men were considered to be asymptomatic noncases. Of the 19091 men who had had a digital-rectal examination by 1992, 3180 reported having an enlarged prostate.

The mean age of the 33344 men at baseline in 1986 was 53.4 ± 9.3 y (median: 53 y), and the mean total daily energy (excluding that from alcohol), fat, protein, and carbohydrate intakes were 8030 ± 2355 kJ (median: 7687 kJ), 71.4 ± 13.8 g (median: 71.8 g), 92.2 ± 16.3 g (median: 91.3 g), and 234.4 ± 42.0 g (median: 234 g), respectively. Age-standardized means and prevalences of suspected BPH risk factors and other factors characterizing the participants in the highest and lowest quintiles of macronutrient intake are shown in Table 1. Most of the P values for trend were significant because of the large sample size.

The ORs for specific case definitions of BPH differed by type of fat intake. Animal fat intake was not associated with total BPH (Table 4), BPH surgery, or high-moderate to severe lower urinary tract symptoms. However, animal fat intake was slightly inversely related to enlarged prostate after multivariate adjustment (OR: 0.86; 95% CI: 0.75, 0.98; P for trend = 0.03; Table 3). Vegetable fat intake was positively associated with total BPH and high-moderate to severe lower urinary tract symptoms, but not with BPH surgery or enlarged prostate, although the magnitudes of the associations were small. We observed similar patterns when comparing extreme deciles of animal and vegetable fat intakes.

Palmitic acid intake was not associated with total BPH (Table 5) or high-moderate to severe lower urinary tract symptoms, whereas marginal inverse associations were observed for BPH surgery (OR: 0.83; Table 3) and for enlarged prostate (OR: 0.89; Table 3). Stearic acid intake was significantly inversely associated with BPH surgery (OR: 0.77; Table 3). However, this association was not observed for the other BPH endpoints.

Intakes of linoleic and arachidonic acids were slightly positively associated with total BPH (OR: 1.11 and 1.18, respectively; Table 5) and with high-moderate to severe lower urinary tract symptoms (OR: 1.14 and 1.22; Table 3). These fatty acids were not associated with BPH surgery or enlarged prostate. -Linolenic acid was weakly associated with high-moderate to severe lower urinary tract symptoms only (OR: 1.17; Table 3).

EPA and DHA correlated highly with each other (r = 0.95) because both are primarily from marine sources. As shown in Tables 3 and 5, EPA and DHA were both positively associated with total BPH, and the ORs were slightly higher for DHA. For EPA, the ORs (95% CIs) for total BPH were 1.20 (1.06, 1.35), for BPH surgery were 1.32 (1.11, 1.57), for high-moderate to severe lower urinary tract symptoms were 1.10 (0.94, 1.29), and for enlarged prostate were 1.14 (1.00, 1.30) in a comparison of extreme quintiles; the respective ORs for DHA were 1.23 (1.09, 1.39), 1.32 (1.11, 1.57), 1.17 (1.01, 1.36), and 1.23 (1.08, 1.40). The positive relations of EPA and DHA with total BPH were significant for all definitions except high-moderate to severe lower urinary tract symptoms. The ORs comparing extreme deciles for these 4 definitions of BPH were 1.15 (Table 5), 1.17, 1.15, and 1.15 for EPA, and 1.28 (Table 5), 1.38, 1.22, and 1.23 for DHA, respectively. These relations were consistent across BMIs.

	DISCUSSION

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFEsRENCES

 
Of the 33344 members of the Health Professionals Follow-up Study, we observed direct associations between total energy intake and total BPH and high-moderate to severe lower urinary tract symptoms; between total and animal protein intakes and total BPH and BPH surgery; between EPA and DHA and total BPH, BPH surgery, and enlarged prostate; and between total polyunsaturated fats and all definitions of BPH.

Intakes of total energy and specific macronutrients may affect several aspects of the underlying etiology of BPH and lower urinary tract symptoms. Although the etiology of BPH is unclear, 2 aspects have been emphasized: a static component and a dynamic component. The static component probably results from overgrowth of the prostatic epithelium, which compresses the urethra. Prostatic epithelial cell proliferation is influenced by androgens, as evidenced by the absence of BPH in men who are castrated before puberty (23) and the small or absent prostate in men who are deficient in 5-reductase type 2 (24,25). On the other hand, the dynamic component of BPH appears to be related to the level of sympathetic nervous system activity. _1c-Adrenoceptors have been identified as the major mediator of prostate contractility (26, 27), and contractility is dependent on norepinephrine concentrations (28). Adrenergic receptors are preferentially expressed in the prostate stroma, probably in smooth muscle cells (29), and the ratio of prostatic stroma to epithelium is higher in some men with symptomatic BPH (30).

The positive relation between total energy intake and total BPH is difficult to interpret because variation in total energy intake is due largely to differences in physical activity, body size, and energy efficiency (11). In this cohort, we previously reported an inverse association between physical activity and BPH (20) and a positive association between abdominal obesity and BPH (22). An increase in energy intake may enhance abdominal obesity and sympathetic nervous system activity, both of which may increase the risk of BPH. However, higher energy intakes related to physical activity do not appear to increase BPH risk. In the present study, we adjusted for BMI and physical activity. Also, the relation between energy intake and BPH was essentially the same in the analyses that were stratified by tertile of BMI (data not shown). Thus, it is not likely that total energy intake represented physical activity or body size in the present study. One possibility for the positive relation between total energy intake and total BPH is that activation of the sympathetic nervous system by a high energy intake (31) may cause the prostate smooth muscle to contract, resulting in a worsening of lower urinary tract symptoms. The positive relation of total BPH with total energy intake could also be indirect if low metabolic efficiency results in both higher symptomatic tone and higher energy intakes. The lack of an association between total energy intake and enlarged prostate suggests that the effect of energy intake is mediated through the dynamic rather than the static component of BPH.

Positive relations of total and animal protein intakes with total BPH and BPH surgery were observed. Because there were no associations between enlarged prostate and protein intake in this study, the etiology of BPH also could be explained by the dynamic rather than the static component of BPH. However, protein intake was not associated with high-moderate to severe lower urinary tract symptoms. Furthermore, the relation of dietary protein with sympathetic nervous system activity is reported to be less strong than that of dietary carbohydrate intake in humans (32) and rats (33) in short-term studies. Also, a study of vegetarians suggested that protein might lower sympathetic nervous system activity (34). These observations indicate that protein may not be associated with BPH surgery as a result of higher sympathetic nervous system activation. Another plausible role of protein may be related to its contribution to the osmolar concentration of the diet that increases the obligatory water loss, which may increase urination (100 g protein contains 16 g N that must be excreted, mostly as urea, contributing 500 mOsmol). Because the kidneys can only concentrate urine up to a certain osmolality, the osmolar concentration of the diet, which is largely related to protein and salt, induces an obligatory water loss. It is plausible that the osmolar load from a large protein meal as it is digested influences urinary flow, which may exacerbate any existing urinary symptoms. This mechanism is speculative because it is unclear whether the magnitude of changes in urinary flow is sufficient to produce symptoms.

EPA and DHA were associated with total BPH, BPH surgery, and enlarged prostate. These polyunsaturated fatty acids were most clearly related to enlarged prostate, suggesting a mechanism of BPH etiology different from that of the other nutrients. The high degree of unsaturation of EPA and DHA suggests a mechanism involving lipid peroxidation. Lipid peroxides may result in increases in tissue concentrations of NAD and NADPH, which increase 5-reductase and prostatic DHT concentrations, thus possibly increasing epithelial and stromal growth (1). A hormonal etiology appears consistent with the finding that EPA and DHA were associated with the mechanical, or static, component rather than with the dynamic component of BPH. A weak positive association between vegetable fat and total BPH and high-moderate to severe lower urinary tract symptoms and enlarged prostate also might be due to peroxidation. Serum DHT is reported to be positively correlated with vegetable fat intake (35), but the relation between plasma hormones and BPH risk is controversial (36). The degree of unsaturation of fatty acids in cell membranes appears to influence 5-reductase activity (13), which is a determinant of intracellular DHT concentrations in the prostate.

Besides a mechanism involving androgenic effects, numerous previous studies have shown that lipid peroxides are involved in the regulation of cellar proliferation and cytotoxicity. Dietary EPA and DHA are sources of lipid peroxides, and their cytotoxicity is concentration dependent (37) and may influence BPH through nonhormonal mechanisms (38). The results of an animal study suggest that n-3 polyunsaturated fatty acids suppress sympathetic nervous system activity (39), which does not support a positive effect on the dynamic component of BPH.

There are few reports on the relations between intake of foods or macronutrients and BPH. An ecologic study in China (7) suggests that the increasing prevalence of BPH in China may be attributed to the increased intakes of total energy, fat, and animal protein. A case-control study (n = 100 cases and 100 matched control subjects) conducted in Japan reported a positive association between BPH and regular milk consumption (OR: 2.3) and daily meat consumption (OR: 3.2) (8). A cohort study (9) reported a weak positive relation between beef consumption (consumption of 180 g/wk compared with nonconsumers) and BPH surgery (OR: 1.3; P = 0.05). A case-control study of 184 BPH patients and 244 control subjects found that butter, margarine, and seed oils were related to a higher risk of BPH; margarine and seed oils are sources of polyunsaturated fat (10).

Some strengths of our study were its large size, prospective assessment of diet, and ability to control for numerous potentially confounding factors. Although there is some degree of misclassification when both diet and BPH are assessed, the large sample size in the present study increased the likelihood that important associations would be detected even if they were attenuated by measurement error. Because diet was assessed prospectively, misclassification should have been largely nondifferential between cases and noncases. Thus, the true underlying associations may be even stronger than observed. To the extent that we could control for various factors, confounding did not appear to account for the observed associations, although this possibility cannot be entirely excluded. Although we made no direct clinical measures to diagnose BPH, our multiple assessments of various aspects of BPH enhanced the likelihood of our detecting any associations. The greatest credibility should be given to results that were consistent across all or most endpoints; the results for nutrients associated with only one endpoint should be viewed with more caution.

In this study, we reported on associations between BPH and macronutrient intakes. The associations were modest, and any changes in diet must be considered in conjunction with other important diseases, such as cancer and heart disease. Our findings on polyunsaturated fatty acids need to be explored further because unsaturated fats and fish oils are beneficial in preventing heart disease. If the associations related to fatty acids are due to oxidative stress, the role of antioxidants needs to be considered to arrive at the optimal diet, taking into account overall health.

	ACKNOWLEDGMENTS

 
We are indebted to Kathleen Markham, Elizabeth Frost-Hawes, Mira Kaufman, Kerry Demers, and Alvin Wing for their expert help.

	REFEsRENCES

TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFEsRENCES

 

1. Bostwick D. Pathology of benign prostatic hyperplasia. In: Kerby R, McConnell J, Fitzpatrick J, et al, eds. Textbook of benign prostatic hyperplasia. Oxford, United Kingdom: ISIS Medical Media, Ltd, 1996:91–104.
2. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474–9.[Medline]
3. Graves EJ, Gillum BS. Detailed diagnoses and procedures, National Hospital Disease Survey, 1994. Vital Health Stat 13 1997;130:1–146.
4. Caine M. The present role of -adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 1986;136:1–4.[Medline]
5. Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992;327:1185–91.[Abstract]
6. Lefèvre-Borg F, O'Connor SE, Schoemaker H, et al. Alfuzosin, a selective ₁-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol 1993;109:1282–9.[Medline]
7. Gu F. Changes in the prevalence of benign prostatic hyperplasia in China. Chin Med J 1997;110:163–6.[Medline]
8. Araki H, Watanabe H, Mishina T, Nakao M. High-risk group for benign prostatic hypertrophy. Prostate 1983;4:253–64.[Medline]
9. Chyou PH, Nomura AMY, Stemmermann GN, Hankin JH. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate 1993;22:253–64.[Medline]
10. Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO, Trichopoulos D. Diet and benign prostatic hyperplasia: a study in Greece. Urology 1999;54:284–9.[Medline]
11. Willett WC. Nutrition epidemiology. 2nd ed. New York: Oxford University Press, 1998:273–301.
12. Liang T, Liao S. Inhibition of steroid 5-reductase by specific aliphatic unsaturated fatty acids. Biochem J 1992;285:557–62.
13. Weisser H, Krieg M. Fatty acid composition of phospholipids in epithelium and stroma of human benign prostatic hyperplasia. Prostate 1998;36:235–43.[Medline]
14. Rimm EB, Giovannucci E, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproductivity and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114–26.[Abstract/Free Full Text]
15. Rimm EB, Stampfer MJ, Colditz GA, Giovannucci E, Willett WC. Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study. Am J Epidemiol 1990;131:1068–71.[Abstract/Free Full Text]
16. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549–57.[Medline]
17. Ascherio A, Stampfer MJ, Colditz GA, Rimm EB, Litin LB, Willett WC. Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherol among American men and women. J Nutr 1992;122:1792–801.
18. US Department of Agriculture. Consumption of foods: raw, processed and prepared. Agriculture handbook no. 8 series. Washington, DC: US Government Printing Office, 1963–1988.
19. Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E. Race and ethnicity and benign prostatic hyperplasia. J Urol 2000;163:490–5.[Medline]
20. Platz EA, Kawachi I, Rimm EB, et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998;158:2349–56.[Abstract/Free Full Text]
21. Platz EA, Rimm EB, Kawachi I, et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol 1999;149:106–15.[Abstract/Free Full Text]
22. Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994;140:989–1002.[Abstract/Free Full Text]
23. Wilson JD. The pathogenesis of benign prostatic hyperplasia. Am J Med 1980;68:745–56.[Medline]
24. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974;186:1213–5.[Abstract/Free Full Text]
25. Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of steroid 5-reductase 2 gene in male pseudohermaphroditism. Nature 1991;354:159–61.[Medline]
26. Forray C, Bard JA, Wetzel, et al. The ₁-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human _1c subtype. Mol Pharmacol 1994;45:703–8.[Abstract]
27. Marshall I, Burt RP, Chapple CR. Noradrenaline contractions of human prostate mediated by _1A-(_1c-) adrenoceptor subtype. Br J Pharmacol 1995;115:781–6.[Medline]
28. Hedlund H, Andersson KE, Larsson B. Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol 1985; 134:1291–8.[Medline]
29. Chapple CR, Aubry ML, James S, et al. Characterisation of human prostatic adrenoceptors using pharmacology receptor binding and localisation. Br J Urol 1989;63:487–96.[Medline]
30. Shapiro E, Becich MJ, Hartanto V, Lepor H. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol 1992;147:1293–7.[Medline]
31. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17:669–77.[Abstract/Free Full Text]
32. Fagius J, Berne C. Increase in muscle nerve sympathetic activity in humans after food intake. Clin Sci 1994;86:159–67.[Medline]
33. Brito MN, Brito NA, Garófalo MAR, Kettelhut IC, Migliorini RH. Sympathetic activity in brown adipose tissue from rats adapted to a high protein, carbohydrate-free diet. J Auton Nerv Syst 1998;69:1–5.[Medline]
34. Beilin LJ. Vegetarian approach to hypertension. Can J Physiol Pharmacol 1986;64:852–5.[Medline]
35. Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994;79:1310–6.[Abstract]
36. Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, Stampfer MJ. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995;26:40–9.[Medline]
37. Cepinskas G, Kvietys PR, Aw TY. ₃-lipid peroxides injure CaCo-2 cells: relationship to the development of reduced glutathione antioxidant systems. Gastroenterology 1994;107:80–6.[Medline]
38. Jonas A, Rosenblat G, Krapf D, Bitterman W, Neeman I. Cactus flower extracts may prove beneficial in benign prostatic hyperplasia due to inhibition of 5 reductase activity, aromatase activity and lipid peroxidation. Urol Res 1998;26:265–70.[Medline]
39. Head RJ, Mano MT, Bexis S, Howe PRC, Smith RM. Dietary fish oil administration retards the development of hypertension and influences vascular neuroeffector function in the stroke prone spontaneously hypertensive rat (SHRSP). Prostaglandins Leukot Essent Fatty Acids 1991;44:119–22.[Medline]

This article has been cited by other articles:

				A. R. Kristal, K. B. Arnold, J. M. Schenk, M. L. Neuhouser, P. Goodman, D. F. Penson, and I. M. Thompson Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial Am. J. Epidemiol., April 15, 2008; 167(8): 925 - 934. [Abstract] [Full Text] [PDF]

				S. Rohrmann, E. Giovannucci, W. C Willett, and E. A Platz Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men Am. J. Clinical Nutrition, February 1, 2007; 85(2): 523 - 529. [Abstract] [Full Text] [PDF]

				J. K. Parsons, H. B. Carter, A. W. Partin, B. G. Windham, E. J. Metter, L. Ferrucci, P. Landis, and E. A. Platz Metabolic Factors Associated with Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2562 - 2568. [Abstract] [Full Text] [PDF]

				R. Hakkarainen, T. Partonen, J. Haukka, J. Virtamo, D. Albanes, and J. Lonnqvist Is Low Dietary Intake of Omega-3 Fatty Acids Associated With Depression? Am J Psychiatry, March 1, 2004; 161(3): 567 - 569. [Abstract] [Full Text] [PDF]

				D. Heber Prostate enlargement: the canary in the coal mine? Am. J. Clinical Nutrition, April 1, 2002; 75(4): 605 - 606. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suzuki, S. Articles by Giovannucci, E. Search for Related Content PubMed PubMed Citation Articles by Suzuki, S. Articles by Giovannucci, E. Agricola Articles by Suzuki, S. Articles by Giovannucci, E.